Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Triamcinolone acetonide + povidone-iodine + lidocaine hydrochloride + bupivacaine** is a multi-component procedural kit containing a depot synthetic glucocorticoid, two amide local anesthetics, and a topical antiseptic. Triamcinolone acetonide activates glucocorticoid receptors to suppress inflammatory signaling; lidocaine and bupivacaine inhibit voltage-gated sodium-channel-dependent nerve conduction to provide local or regional anesthesia and analgesia; and povidone-iodine provides local antimicrobial antisepsis. The exact four-component presentation is listed in DailyMed as **MLK F4 Kit**; related P-Care kit presentations package these agents with ancillary sodium chloride and isopropyl-alcohol products. MLK F4 Kit is listed as an unapproved drug other product in FDA NDC-derived labeling, so the combination itself should not be interpreted as an FDA-approved fixed-dose medicine. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=829e3bd1-fb1c-4613-9db3-9a89ef8e2c0c))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on triamcinolone acetonide + povidone-iodine + lidocaine hydrochloride + bupivacaine.